Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer

Figure 7

Pan-cancer analysis showed MRPL13 was upregulated in BRCA.

(a)

(b)

(c)

(d)